Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Giuseppe Pezzella
Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncologico Dell’Italia Meridionale
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Related publications
A Phase 2 Randomised Study of Veliparib Plus FOLFIRI±bevacizumab Versus Placebo Plus FOLFIRI±bevacizumab in Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
Safety and Efficacy of Docetaxel Plus Cisplatin Versus Cisplatin Concurrent With Radiation in Local Advanced Cervical Cancer: Midterm Results of a Phase III, Multicenter and Randomized Trial
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Doxorubicin and 5-Fluorouracil Versus Doxorubicin and Oral Ftorafur in the Treatment of Advanced Gastric Cancer—a Phase II and III Trial
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Interim Analysis of Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin Versus Capecitabine Alone for Pathological Stage II and III Rectal Cancer: A Randomized Multicenter Phase III Trial
Oncotarget
Oncology
a Phase II, Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab in Combination With FOLFIRI for the Second‐Line Treatment of Metastatic KRAS Mutant Colorectal Adenocarcinoma
Oncologist
Cancer Research
Medicine
Oncology
A Randomised, Double-Blind, Placebo-Controlled Multi-Centre Phase III Trial of XELIRI/FOLFIRI Plus Simvastatin for Patients With Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
Carboplatin Versus Alternating Carboplatin and Doxorubicin for the Adjuvant Treatment of Canine Appendicular Osteosarcoma: A Randomized, Phase III Trial
Veterinary and Comparative Oncology
Veterinary
A Trial Protocol of Biweekly TAS-102 and Bevacizumab as Third-Line Chemotherapy for Advanced/Recurrent Colorectal Cancer: A Phase II Multicenter Clinical Trial (The TAS-CC4 Study)
Journal of the Anus, Rectum and Colon
Phase II Trial of UFT in Advanced Colorectal and Gastric Cancer
British Journal of Cancer
Cancer Research
Oncology